Drug profile · INN
delavirdine mesylate
RESCRIPTOR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
delavirdine mesylate (RESCRIPTOR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN delavirdine mesylate
Brand RESCRIPTOR
Route ORAL
Formulation TABLET
Frequently asked questions
What is delavirdine mesylate?
delavirdine mesylate (RESCRIPTOR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for delavirdine mesylate?
RESCRIPTOR is a marketed brand name for delavirdine mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of delavirdine mesylate?
delavirdine mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.